The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000.00 firm-fixed-price definitive contract to Zymeron Corporation, a minority-owned small business, to provide rapid point-of-care tests to quantify hepatitis C virus. The contract has an estimated completion date of August 30, 2022 and was awarded on August 31, 2021. Zymeron is a research-based biotechnology company that develops innovative technologies for areas such as infectious disease diagnostics and therapies. This contract supports Zymeron's capabilities in delivering medical research, engineering services, and biotech products to federal agencies under vehicles like the Small Business Innovation Research (SBIR) program.
Generated 3/22/24, 12:09 AM